Advertisement

HTRA1 enhance signaling pathway of uveitis via modulation of the TGF-β signaling cascade


 

 

 

 

 

 

American Journal of BioMedicine  Volume 2, Issue 12, pages1240-1253 December 2014


Sascha Vierkotten; Victoria Korinek; Philip Frugier

Abstract

High temperature requirement protein A1 (HtrA1) is a serine protease that is mostly secreted to degrade numerous extracellular matrix proteins, They are involved in the development and progression of several pathological processes such as cancer, neurodegenerative disorders and arthritic diseases, but it also exists within cells for some partially understood. The purpose of this study was to investigate the role of HTRA1 in the uveitis, and the possible mechanisms involved. Interphotoreceptor retinoid-binding protein peptide R14 to induced uveitis in rat model. A recombinant lentiviral vector carrying HTRA1-shRNA to knockdown HTRA1 expression. ELISA to detected proinflammatory cytokines and standard molecular biological techniques were used for subcloning of HtrA1. The knockdown of HTRA1 was associated with decreased the cellularlevel expression of proinflammatory cytokine resulted in reduced cellular damage, and increased mRNA levels of TGF-β1.

Key words: HtrA1; Uveitis; Proinflammatory cytokines; TGF-β


Limited Access             Full Text-PDF                Feedback


References

1. Shiga A, Nozaki H, Yokoseki A, et al. Cerebral small-vessel disease protein HTRA1 controls the amount of TGF-beta1 via cleavage of proTGF-beta1. Hum Mol Genet 2011;20:1800–1810. [PubMed]

2. Grau S, Baldi A, Bussani R, et al. Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proc Natl Acad Sci USA 2005;102:6021–6026. [PubMed]

3. Hansen G, Hilgenfeld R. Architecture and regulation of HtrA-family proteins involved in protein quality control and stress response. Cell Mol Life Sci 2013;70:761–775. [PubMed]

4. Krojer T, Sawa J, Schafer E, et al. Structural basis for the regulated protease and chaperone function of DegP. Nature 2008;453:885–890. [PubMed]

5. Grau S, Richards PJ, Kerr B, et al. The role of human HtrA1 in arthritic disease. J Biol Chem 2006;281:6124–6129. [PubMed]

6. Chien J, Campioni M, Shridhar V, Baldi A. HtrA serine proteases as potential therapeutic targets in cancer. Curr Cancer Drug Targets 2009;9:451–468. [PubMed]

7. Bansal R, Gupta V, Gupta A. Current approach in the diagnosis and management of panuveitis. Indian J Ophthalmol 2010;58: 45–54. [PubMed]

8. Thorne JE, Jabs DA, Peters GB, et al. Birdshot retinochoroidopathy: ocular complications and visual impairment. Am J Ophthalmol 2005;140: 45–51. [PubMed]

9. Smith JR, Verwaerde C, Rolling F, et al.Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitis. Hum Gene Ther 2005;16: 1037–1046. [PubMed]

10. Kowalczuk L, Touchard E, Camelo S, et al. Local ocular immunomodulation resulting from electrotransfer of plasmid encoding soluble TNF receptors in the ciliary muscle. Invest Ophthalmol Vis Sci 3009;50: 1761–1768. [PubMed]

11. Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201: 233–240. [PubMed]

12. Tsutsui K, Mueller GC. A protein with multiple heme-binding sites from rabbit serum. J Biol Chem 1982;257:3925–3931. [PubMed]

13. Nishimoto Y, Shibata M, Nihonmatsu M, et al. A novel mutation in the HTRA1 gene causes CARASIL without alopecia. Neurology 2011;76:1353–1355. [PubMed]

14. Murray PI, Clay CD, Mappin C, Salmon M. Molecular analysis of resolving immune responses in uveitis. Clin Exp Immunol 1999;117: 455–461. [PubMed]

15. Curtis SD, Aderaye S, Bower J. The additive effect of TGF-ß with TNF-α on type VII collagen gene expression to activate the expression of an extracellular matrix-related gene. American Journal of BioMedicine 2014;2:56–66. [Abstract/ Full-Text]

16. Eperon S, Rodriguez-Aller M, Balaskas K, Gurny R, Guex-Crosier Y. A new drug delivery system inhibits uveitis in an animal model after cataract surgery. Int J Pharm 2013;443: 254–261. [PubMed]

17. Siddique SS, Shah R, Suelves AM, Foster CS. Road to remission: a comprehensive review of therapy in uveitis. Expert Opin Investig Drugs 2011; 20: 1497–1515. [PubMed]

18. Gutteridge IF, Hall AJ. Acute anterior uveitis in primary care. Clinical and Experimental Optometry 2007;90: 70–82. [PubMed]

19. Paivonsalo-Hietanen T, Tuominen J, Vaahtoranta-Lehtonen H, Saari KM. Incidence and prevalence of different uveitis entities in Finland. Acta Ophthalmol Scand 1997;75: 76–81. [PubMed]

20. Dandona L, Dandona R, John RK, McCarty CA, Rao GN. Population based assessment of uveitis in an urban population in southern India. Br J Ophthalmol 2000;84: 706–709. [PubMed]

American Journal of Biomedicine © 2017 Frontier Theme
%d bloggers like this: